Atsuko Takano-Hayata
Suita, 5650871, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Neuron-specific overexpression of human vasoactive intestinal peptide receptor 2 in mice causes cognitive dysfunction and abnormal dendritic morphology in the prefrontal cortex.
Journal: Journal of pharmacological sciences
Published: September 15, 2025
Recovery of centralities in medial prefrontal and sensory-related cortices associated with social behavior improvements in an autism mouse model.
Journal: Scientific reports
Published: December 19, 2024
Strategy for the development of small-molecule antidepressant targeting PAC1 receptor
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: June 30, 2024
Rapid and long-lasting antidepressant-like effects of the pituitary adenylate cyclase-activating polypeptide receptor antagonist PA-915 in chronic stress mouse models.
Journal: Molecular psychiatry
Published: June 17, 2024
Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells.
Journal: Journal of pharmacological sciences
Published: November 01, 2023
Pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment.
Journal: Journal of pharmacological sciences
Published: June 30, 2023
Small-molecule non-peptide antagonists of the PACAP receptor attenuate acute restraint stress-induced anxiety-like behaviors in mice.
Journal: Biochemical and biophysical research communications
Published: August 22, 2022
Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migration.
Journal: Frontiers in oncology
Published: January 12, 2022
Last Updated: 09/26/2026